On Thursday, Mr. Gandhi posted an animated graphic that showed India soaring past United States and Brazil in terms of registering daily new cases, against the Prime Minister’s statement that the situation in India has been ‘manageable’ to a great extent because of acting on time.
Russia has made the vaccine race a matter of national prestige and has named the product ‘Sputnik V’ after the former Soviet space satellites, prompting fears that safety will be compromised for the sake of Russia’s image.
Results published May 22 in The Lancet showed most of the people dosed with the vaccine had immune responses, although their levels of antibodies thought to neutralize the virus were relatively low. Researchers saw a stronger ramp-up of other immune compounds, called T-cells, that might also help fight the infection off.
In an early-stage trial, Novavax’s vaccine candidate, NVX-CoV2373, has produced higher levels of antibodies in healthy volunteers after two doses than those found in recovered COVID-19 patients and the vaccine was “well tolerated” overall.
The shot did not cause any serious side effects, according to a paper published on Thursday in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes.
The job of a Covid-19 vaccine is to inoculate broadly against the virus, putting enough roadblocks in its transmission path so that the pandemic stalls. How to do that most efficiently is far from clear, but there is some agreement over who will get priority: those most at risk of death or contagion, such as […]
Meanwhile, COVID-19 cases in India appear to be galloping ahead. According to the Indian Ministry of Health and Family Welfare, the total caseload has topped 2.46 million, while the pandemic has claimed 48,040 lives. However, over 1.75 million people have been discharged or cured as well.
“Medicine: The Wellcome Galleries” tracks medical advances through history, and its timely displays include an iron lung used for polio patients in the 1950s, an isolation trolley from the 1970s, PPE from the Ebola epidemic and statistics on the effectiveness of vaccinations.
Dr. Anna Durbin, a vaccine researcher at the Johns Hopkins Bloomberg School of Public Health, who has run a dozen challenge studies, estimates it could take nine to 12 months to set up a human challenge trial, and another six months to coordinate testing across multiple testing sites.
Covid-19: the current count in IndiaAs of Tuesday evening, India’s total tally of Covid-19 cases was 911,629, out of which 573,953 people have recovered and 23,788 have died due to the virus. Globally, the virus has so far infected 13,267,250 and reportedly killed 576,316.Covid-19 vaccine & costMaintaining momentum, Bharat Biotech has started the first phase […]